Private Advisor Group LLC reduced its position in shares of Masimo Co. (NASDAQ:MASI) by 9.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,158 shares of the medical equipment provider’s stock after selling 1,002 shares during the period. Private Advisor Group LLC’s holdings in Masimo were worth $891,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. USA Mutuals Advisors Inc. purchased a new position in shares of Masimo during the fourth quarter worth $110,000. SeaCrest Wealth Management LLC purchased a new position in shares of Masimo during the fourth quarter worth $116,000. DekaBank Deutsche Girozentrale boosted its position in shares of Masimo by 78.3% during the third quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after buying an additional 925 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Masimo by 39.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock worth $239,000 after buying an additional 802 shares during the period. Finally, Jane Street Group LLC purchased a new position in shares of Masimo during the third quarter worth $317,000. Institutional investors and hedge funds own 82.18% of the company’s stock.
MASI has been the subject of several research analyst reports. Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a research report on Thursday, November 2nd. Stifel Nicolaus restated a “buy” rating and set a $108.00 price target on shares of Masimo in a research report on Friday, November 3rd. Finally, BidaskClub lowered Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $104.60.
In related news, Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $93.07, for a total value of $186,140.00. Following the completion of the transaction, the director now directly owns 68,249 shares in the company, valued at $6,351,934.43. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Yongsam Lee sold 10,000 shares of Masimo stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $92.95, for a total value of $929,500.00. Following the completion of the transaction, the executive vice president now owns 79,000 shares of the company’s stock, valued at $7,343,050. The disclosure for this sale can be found here. Over the last quarter, insiders sold 48,098 shares of company stock valued at $4,315,261. 13.10% of the stock is currently owned by company insiders.
Masimo Co. (MASI) opened at $85.58 on Wednesday. Masimo Co. has a 52-week low of $80.69 and a 52-week high of $104.71. The company has a market capitalization of $4,478.85, a price-to-earnings ratio of 13.54, a PEG ratio of 3.29 and a beta of 0.85.
TRADEMARK VIOLATION WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/21/masimo-co-masi-holdings-cut-by-private-advisor-group-llc.html.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.